Bio tech company updates — 11/13/2026
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Korean biotech news in the past 24 hours spans new clinical-trial testing capacity at GCCL and Alteogen’s planned first appearance at the Jefferies Global Healthcare Conference. Officials also pledged stronger biotech R&D support and faster drug approvals, while forum speakers called for a closer drug-development alliance.
Key Findings
- GCCL is installing a BD FACSDiscover A7 flow cytometer to expand immune-cell analysis services for clinical trials; the report describes it as a first for Korea’s clinical-trial testing industry.
- Alteogen said it will attend the 2026 Jefferies Global Healthcare Conference in London from Nov. 16 to 19, marking its first participation.
- Korean officials pledged increased biotech R&D investment and faster drug approvals, with the approval timeline described as cut to 240 days.
- Speakers at the 2026 Biomedical Forum urged a drug-development alliance linking biotech ventures, pharmaceutical companies, hospitals and government.
Details
GCCL is adding the BD FACSDiscover A7 flow cytometer as it expands immune-cell analysis for clinical-trial testing. The report characterizes the installation as the first of its kind in Korea’s clinical-trial testing industry.
Alteogen announced that it will take part in the Jefferies Global Healthcare Conference for the first time. The London conference is scheduled for Nov. 16–19, 2026.
At the 5th Seoul Economic Daily Biomedical Forum, Korean officials pledged increased R&D investment in biotechnology and faster drug approvals. The report says the approval timeline has been cut to 240 days.
A separate forum report describes calls for a drug-development alliance connecting biotech ventures, drugmakers, hospitals and government. The proposal centers on linking participants across the development process, from laboratory research through manufacturing.
Sources
Korean Biotechs Head to BIO-Europe to Pitch Obesity, Cancer Drugs - Seoul Economic Daily
GCCL Adds Advanced Immune Cell Analyzer to Expand Clinical Trial Testing - Seoul Economic Daily
Korea Vows Faster Drug Approvals, Bigger R&D Push for Biotech - Seoul Economic Daily
Alteogen Joins Jefferies Healthcare Conference for First Time - Seoul Economic Daily
Hanmi Executive: Korea Must Out-Design China
en.sedaily.com
en.sedaily.com
en.sedaily.com
en.sedaily.com
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
